Riskpilot← Back to searchSign inGet full accessNORAMIX PARTNER AS
ASActiveOrg 926330160Liamyrane 13, 5132 NyborgNon-specialised wholesale trade · NACE 4690Est. 20212 employees
Revenue 2024
NOK 36,2M
+40% vs 2023
EBITDA margin
0.4%
-71% vs 2023
Equity ratio
58.0%
Financial strength
Net profit 2024
NOK 160K
-53% vs 2023
| Revenue | NOK 36,2M | +40% |
| EBITDA | NOK 152K | -71% |
| Net profit | NOK 160K | -53% |
| Total assets | NOK 6,1M | -18% |
| Equity | NOK 3,5M | -1% |
| Employees | 2 | — |
Legal name
NORAMIX PARTNER AS
Org number
926330160
Legal form
Aksjeselskap
NACE code
4690 · Non-specialised wholesale trade
Founded
5. januar 2021
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Kjøp av varer for videresalg til andre næringsdrivende, herunder men ikke begrenset til grossister, butikkjeder og lignende.
Address
Liamyrane 13, 5132 Nyborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 580 | 2 975 | 15 592 | 25 826 | 36 211 |
| Staff expenses | −0 | −0 | −368 | −1 548 | −1 265 |
| EBITDA | 37 | 715 | 3 829 | 528 | 152 |
| Depreciation & amort. | −0 | −20 | −48 | −56 | −56 |
| EBIT | 37 | 695 | 3 781 | 472 | 96 |
| Net financials | 0 | 17 | −57 | −39 | 109 |
| Profit before tax | 37 | 712 | 3 724 | 433 | 205 |
| Tax | 8 | 157 | 819 | 95 | 45 |
| Net profit | 29 | 555 | 2 905 | 337 | 160 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 610 | 1 826 | 6 705 | 7 395 | 6 070 |
| Equity | 59 | 608 | 3 513 | 3 559 | 3 518 |
| Long-term debt | 543 | 4 | 0 | 0 | 0 |
| Short-term debt | 8 | 1 214 | 3 192 | 3 835 | 2 551 |
| Total debt | 551 | 1 218 | 3 192 | 3 836 | 2 551 |
EBITDA margin
0.4%
This company
15.8%
Market median
-97% vs market
20202024
Equity ratio
58.0%
This company
38.2%
Market median
+52% vs market
20202024
Return on equity
4.5%
This company
18.4%
Market median
-76% vs market
20202024
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
20202024
Asset turnover
5.97×
This company
1.12×
Market median
+433% vs market
20202024
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RE Deputy Member | Deputy Member | 2021 | — | — |
MB Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
KR Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Noramix Handel As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Noramix Invest As
NORAMIX PARTNER AS Board members of NORAMIX PARTNER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Randi Elisabeth Kalvik Rasamanickam | Deputy Member | 0 companies |
| Marius Bjørn Nielsen | Chief Executive Officer | 0 companies |
| Keerthivarman Rasamanickam | Chief Executive Officer | 0 companies |